mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.0008 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.2 |
0.001 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.002 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |